Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shot up 13.1% on Monday . The company traded as high as $57.69 and last traded at $58.10. 6,508,913 shares traded hands during trading, a decline of 52% from the average session volume of 13,653,986 shares. The stock had previously closed at $51.35.
Analyst Upgrades and Downgrades
TEM has been the subject of several analyst reports. Morgan Stanley increased their target price on shares of Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Piper Sandler lowered their target price on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Bank of America increased their price target on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. JPMorgan Chase & Co. downgraded Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price objective for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Finally, William Blair reiterated a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $61.18.
Check Out Our Latest Report on TEM
Tempus AI Price Performance
The business's 50 day simple moving average is $57.42 and its 200 day simple moving average is $51.46. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.
Insiders Place Their Bets
In related news, CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at $3,434,220. This represents a 19.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Nadja West sold 809 shares of the business's stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total value of $41,347.99. Following the transaction, the director now owns 37,705 shares of the company's stock, valued at $1,927,102.55. This trade represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,598,969 shares of company stock valued at $317,194,162 over the last ninety days.
Hedge Funds Weigh In On Tempus AI
Large investors have recently bought and sold shares of the business. Operose Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter worth $25,000. First Horizon Advisors Inc. bought a new stake in Tempus AI during the 3rd quarter valued at about $30,000. Farther Finance Advisors LLC purchased a new stake in Tempus AI in the 4th quarter valued at about $34,000. Prestige Wealth Management Group LLC increased its position in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares during the period. Finally, NewEdge Advisors LLC purchased a new stake in shares of Tempus AI in the fourth quarter valued at approximately $49,000. Hedge funds and other institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
